Form 4: Sensei Biotherapeutics Director Vojta Acquires 19,000 Stock Options

Director Deneen Vojta acquired 19,000 stock options in Sensei Biotherapeutics, Inc. at an exercise price of $0.709 on June 11, 2024.

Summary

• On June 11, 2024, Deneen Vojta, a director of Sensei Biotherapeutics, Inc., acquired 19,000 stock options.
• The exercise price of these options is $0.709.
• The options vest in 12 equal monthly installments, becoming fully vested by June 11, 2025, contingent upon continuous service with the Issuer.
• The options will be fully vested on the date of the Company's next annual stockholder meeting, subject to continuous service with the Issuer through such vesting date.
• The expiration date for these options is June 10, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. It doesn't inherently indicate positive or negative sentiment, but rather provides information about insider activity.

Positives

• The acquisition of stock options by a director signals confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a director can be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

stock options, Sensei Biotherapeutics, director, Deneen Vojta, SNSE, acquisition, Form 4